Abstract:Fructus Bruceae is a Chinese Traditional Medicine that commonly used for the treatment of tumor diseases.Brusatol is one of the major active components in Fructus Bruceae.This study was to explore the inhibitory effects of brusatol against proliferation of human prostate cancer DU145 cells,and the molecular mechanism of apop-tosis induced by brusatol was further investigated.The inhibitory activities of brusatol against human prostate cancer cells DU145 and PC3,hepatocellular carcinoma cell HepG2,human breast adenocarcinoma cell MCF-7,human colonadenocarcinoma cell HT-29,human pulmonary carcinoma cell A549 were assessed by MTT assay.The time-and con-centration-dependent inhibition by brusatol on the most sensitive DU145 cells were further studied,and Hoechst 33258 staining was used to observe cellular morphologic changes.The distribution of cell cycle and apoptosis were an-alyzed by flow cytometry through PI and Annexin-V/FITC-PI double-labeled staining.To further analyze the possible mechanism of cell apoptosis,we investigated the protein expression levels of MAPK signaling pathway in DU145 cells after treatment with brusatol by Western blot.At the same concentration,brusatol showed the most po-tent inhibition on the proliferation of DU145 cells in the MTT assay.Furthermore,brusatol was found to inhibit DU145 cell growth in a time-and concentration-dependent manner.The IC50 of the 48 h time course was (0.27±0.04)μmol·L-1 .Apoptosis was measured by Hoechst 33258 staining,which showed increased fragmented chromatin and apoptotic bodies after the treatment with 0.25 μmol·L-1 of brusatol as compared with the solvent control.A typical subdiploid peak was observed by flow cytometry,and the ratio of subdiploid peak was further increased with the time.Apoptosis of DU145 cells was analyzed by AnnexinV/FITC-PI staining and flow cytometry detection.The ap-optosis rate was increased from 0.7% to 10.6% after the treatment of brusatol for 24 h,which confirmed that brusa-tol could induce apoptosis.Western blot analysis showed that brusatol can affect the expression levels of MAPK su-perfamily at a concentration of 0.25 μmol·L-1 after incubation for 45 min,1.5,3,6,12 and 24 h.Brusatol selectively increased the phosphorylation of p38 and JNK,while decreased the phosphorylation of ERK1/2,all in time-dependent manners.Brusatol could significantly inhibit the proliferation of DU145 cells at a dose-and time-dependent manner, and it could also induce cell apoptosis.The increased phosphorylation of p38 and JNK,while decreased phosphoryla-tion of ERK1/2 suggested that mitogen-activated protein kinase (MAPK)pathway might be involved in the brusatol-induced apoptosis on DU145 cells.Thus brusatol is a potential anticancer drug against the prostate cancer.Further studies to reveal its anticancer properties at the animal level are warranted.

Brusatol Inhibits the Growth of Prostate Cancer Cells and Reduces HIF-1α/VEGF Expression and Glycolysis under Hypoxia

Inhibitory effects of brusatol on human prostate cancer cells DU145 and its molecular mechanism

Brusatol inhibits the growth of renal cell carcinoma by regulating the PTEN/PI3K/AKT pathway

Brusatol Suppresses Bladder Cancer by downregulating the expression of Nrf2

Brassinolide, A Plant Sterol from Pollen of Brassica Napus L., Induces Apoptosis in Human Prostate Cancer Pc-3 Cells

Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway

Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under Hypoxia

Brusatol improves the efficacy of an anti-mouse-PD-1 antibody via inhibiting programmed cell death 1 ligand 1 expression in a murine head and neck squamous cell carcinoma model

Brusatol Enhances The Efficacy Of Chemotherapy By Inhibiting The Nrf2-Mediated Defense Mechanism

Brusatol Sensitizes Endometrial Hyperplasia and Cancer to Progestin by Suppressing NRF2-TET1-AKR1C1-mediated Progestin Metabolism.

Inhibitory Effects of Brusatol Delivered Using Glycosaminoglycan-Placental Chondroitin Sulfate A-modified Nanoparticles on the Proliferation, Migration and Invasion of Cancer Cells

Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K/Akt pathway

Brusatol Sensitizes Endometrial Hyperplasia and Cancer to Progestin by Suppressing Nrf2-Tet1-AKR1C1-Mediated Progestin Metabolism

Brusatol Inhibits Proliferation and Invasion of Glioblastoma by Down-Regulating the Expression of ECM1

Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline Against Pituitary Adenomas

Verbascoside inhibits the epithelial‐mesenchymal transition of prostate cancer cells through high‐mobility group box 1/receptor for advanced glycation end‐products/ TGF ‐β pathway

Targeted Inhibition of Mtor by BML-275 Induces Mitochondrial-Mediated Apoptosis and Autophagy in Prostate Cancer.

Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis

Bortezomib Potentiates Antitumor Activity of Mitoxantrone Through Dampening Wnt/β-catenin Signal Pathway in Prostate Cancer Cells

The Apoptotic and Anti-Warburg Effects of Brassinin in PC-3 Cells via Reactive Oxygen Species Production and the Inhibition of the c-Myc, SIRT1, and β-Catenin Signaling Axis

Brusatol’s anticancer activity and its molecular mechanism: a research update